Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T06:28:57.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed.
    Difference
    0.0%
    Check dated 2026-04-17T02:50:36.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T04:56:24.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No study content or essential features appear affected.
    Difference
    0.0%
    Check dated 2026-03-11T23:52:34.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The page indicates a site-wide revision update to v3.4.2 and removal of the prior government-funding notice; these changes are maintenance-related and do not alter any trial details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T11:58:47.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH operating status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:36:24.000Z thumbnail image

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.